About this episode
Tirzepatide (Mounjaro®) is a new medication for the treatment of type II diabetes with a dual acting mechanism acting as a GLP/GIP agonist. This episode discusses the new mechanism of action, some of the trial info that led to its approval, and its current place in therapy for diabetes management. Marcus Pribyl, PharmD. Current role as of 6/26/23: PGY1 Pharmacy Resident at SSM Health Monroe Clinic. After I am starting a new role at Olympia Medical Center as an Ambulatory Care Clinical Pharmacist.Miaja Anderson, PharmD. Current role as of 6/26/23: PGY1 Pharmacy Resident at SSM Health Monroe Clinic. After, Maija is starting a new role at Monroe Hospital as an Inpatient Pharmacist.
